Biology & Therapy of Myeloid Malignancies Conference

The Biology & Therapy of Myeloid Malignancies Conference provides a comprehensive update on the biology and therapy of myeloid malignancies, highlighting advancements and challenges in understanding and treating these complex diseases.

Key Topics

• novel biomarkers for early diagnosis and prognosis
• combination therapies integrating targeted agents with traditional chemotherapies or immunotherapies
• immune evasion mechanisms and combinatorial approaches
• immunotherapies including CAR T-cell therapy and bispecific antibody treatments
• multidisciplinary collaborations integrating basic, computational, translational, and clinical research
• emerging technologies such as spatial sequencing and advanced imaging techniques
• patient-centric research incorporating patient-reported outcomes and quality of life measures
• innovative preclinical models like patient-derived xenografts and organoids
• development of targeted therapies including FLT3, IDH1/2, Menin inhibitors, and BH3 mimetics
• mechanisms of response and resistance to targeted therapies
• managing treatment-related toxicities and supportive care strategies

Who should Attend

• clinical researchers
• hematologists and oncologists
• translational scientists
• immunotherapy developers
• computational biologists
• medical professionals specializing in blood cancers
• drug development experts
• laboratory technicians and scientists
• biomedical engineers
• healthcare policy makers and administrators